💉To ALS patients in the world, we hope to deliver Japan-originated ALS treatment

By Drugs, Pharmaceutical

💉To ALS patients in the world, we hope to deliver Japan-originated ALS treatment

Health Canada accepts our filing for Edaravone to treat ALS and we established commercializing company in Canada

Mitsubishi Tanabe Pharma Corporation

https://www.mt-pharma.co.jp/e/release/nr/2018/pdf/e_MTPC180410.pdf

More from tokioX :

  1. 💊Fujitsu Develops Molecular Simulation Technology to Effectively Create New Drug Candidates
  2. 💊Sunovion Announces Lonhala Magnair (glycopyrrolate) Inhalation Solution Now Available in the U.S. for the Treatment of COPD
  3. 💊Mitsubishi Tanabe Pharma and Hitachi Utilize AI Technology to Begin Collaborative Creation for Improving Efficiency of Clinical Trials for New Drug Development
  4. 💊FDA PHARMA TODAY
  5. 💊Takeda and Denali Therapeutics Collaborate to Develop and Commercialize Therapies for Neurodegenerative Diseases
  6. 💊Completion of Acquisition of NeuroDerm (100% Ownership)  20171018
  7. 💊Notice Regarding Implementation of New Drug Discovery Program “JOINUS” Using Drug Repositioning Compound Libraries by Astellas Pharma, Mitsubishi Tanabe Pharma and Daiichi Sankyo